Danavish Voglibose 0.3mg Tablet
Danavish Voglibose 0.3mg Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Danavish Voglibose 0.3mg Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Danavish Voglibose 0.3mg Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Danavish Voglibose 0.3mg Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Danavish Voglibose 0.3mg Tablet should be taken just before a meal. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your blood sugar levels. Do not stop taking it suddenly without consulting your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness.
This medicine is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Monitor your blood sugar levels regularly while taking this medicine.
The most common side effects of Danavish Voglibose 0.3mg Tablet include flatulence (gas), stomach pain, loss of appetite, constipation, and diarrhea. Consult your doctor if any of these side effects bother you or do not go away. This medicine by itself does not cause hypoglycemia (low blood sugar levels). However, when used in combination with other diabetes medicines (especially insulin or sulphonylureas), it can lead to hypoglycemia (low blood sugar levels). Such episodes of hypoglycemia will have to be treated by taking plain glucose. Table sugar or common sugar will not help correct low blood sugar levels if you are taking this medicine.
Before taking it, let your doctor know if you have any kidney or liver problems. Do not take this medicine if you have ulceration or inflammation in the bowel (eg. ulcerative colitis or Crohn’s disease). Pregnant or breastfeeding women should also consult their doctor before taking it. Please tell your doctor about all the other medicines you are taking to make sure you are safe. Avoid excessive alcohol intake while taking this medicine as it may increase the risk of hypoglycemia (low blood sugar levels).
03Uses
Type 2 diabetes mellitus
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Danavish Voglibose 0.3mg Tablet is to be taken empty stomach.
05How It Works
Danavish Voglibose 0.3mg Tablet is an anti-diabetic medicine. It inhibits the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meals.
06What If You Miss A Dose?
Q: What if you forget to take Danavish Tablet?
A: If you miss a dose of Danavish Voglibose 0.3mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
07Side Effects
Skin rash
Flatulence
Abdominal pain
Diarrhea
08Safety Information
Alcohol:UNSAFE
It is unsafe to consume alcohol with Danavish Voglibose 0.3mg Tablet.
Pregnancy:SAFE IF PRESCRIBED
Danavish Voglibose 0.3mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding:SAFE IF PRESCRIBED
Danavish Voglibose 0.3mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving:SAFE
Danavish Voglibose 0.3mg Tablet does not usually affect your ability to drive.
Kidney:CAUTION
Danavish Voglibose 0.3mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Danavish Voglibose 0.3mg Tablet may be needed. Please consult your doctor.
Liver:CAUTION
Danavish Voglibose 0.3mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Danavish Voglibose 0.3mg Tablet may be needed. Please consult your doctor.
09Drug Tips
Danavish Voglibose 0.3mg Tablet is used together with other diabetes medicines to control blood sugar and avoid long-term complications.
You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Danavish Voglibose 0.3mg Tablet.
Danavish Voglibose 0.3mg Tablet lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.
Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.
Danavish Voglibose 0.3mg Tablet is used together with other diabetes medicines to control blood sugar and avoid long-term complications.
Danavish Voglibose 0.3mg Tablet lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.
Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.
You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Danavish Voglibose 0.3mg Tablet.
References
Sources and references
Pattanaik SR, Shah P, Baker A, et al. Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus. Journal of Clinical and Diagnostic Research. 2018;12(4):OE08-OE12. [Accessed 21 Sept. 2021] (online) Available from: View
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An alpha glucosidase inhibitor. J Clin Diagn Res. 2013;7(12):3023-3027. [Accessed 21 Sept. 2021] (online) Available from: View
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 12 Mar. 2019] (online) Available from: View
